vimarsana.com
Home
Live Updates
Marvel Biosciences Corp.: Marvel Biosciences Provides Updates on the Status of Its MB-204 Manufacturing Efforts and Sets Out Future Milestones : comparemela.com
Marvel Biosciences Corp.: Marvel Biosciences Provides Updates on the Status of Its MB-204 Manufacturing Efforts and Sets Out Future Milestones
Calgary, Alberta--(Newsfile Corp. - October 15, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased
Related Keywords
Canada ,
Calgary ,
Alberta ,
Canadian ,
Kostenloser Wertpapierhandel ,
Istradefylline Nourianz ,
Mark Williams ,
Zhejiang Ausun Pharmaceutical Co Ltd ,
Marvel Biosciences Corp ,
Marvel Biotechnology Inc ,
Virtus Advisory Group ,
Alberta Newsfile Corp ,
Company Or Marvel ,
Regulation Services Provider ,
Venture Exchange ,
Rod Matheson ,
Both Istradefylline ,
Biosciences Corp ,
Chief Executive Officer ,
Chief Science ,
Marvel ,
Iosciences ,
Orp ,
Rovides ,
Updates ,
Status ,
Manufacturing ,
Efforts ,
Jets ,
Future ,
Ilestones ,
comparemela.com © 2020. All Rights Reserved.